1 / 6

Overdoses of Prescription Pain Medications

Overdoses of Prescription Pain Medications. Overview of Issue & NSC Strategy. Prescription drug overdose is a leading cause of unintentional injury death in America. NSC will seek to stop the trend of increased deaths and reduce annual deaths by 10% over five years.

snana
Download Presentation

Overdoses of Prescription Pain Medications

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Overdoses of Prescription Pain Medications

  2. Overview of Issue & NSC Strategy • Prescription drug overdose is a leading cause of unintentional injury death in America. • NSC will seek to stop the trend of increased deaths and reduce annual deaths by 10% over five years. • NSC will work with partners to reduce the supply of Rx pain medications that are currently being prescribed and misused.This will include advocating for changes in -- • State Laws • Physician/Prescriber Practices • Health Care Insurance/Employer Practices • Employer Recognition and Management of Employees • Public Education about Misuse and Disposal of Rx drugs

  3. NSC Advocacyto change state laws, prescriber and insurance practices • Expanded Use of Prescription Drug Monitoring Programs in every state among all doctors and pharmacists. • Regulation of Pain Clinics. • Establish guidelines that specify the medical conditions eligible for Rx opioid pain medications (example: cancer patients only) • Encourage requirement of prior approval and utilization review for certain medications based on patient diagnosis, patterns of prescribing, duration and dosage. • Encourage licensing boards to restrict or remove licenses of prescribers involved in misuse • Promote “lock in” programs that restrict patients to one physician/one pharmacy for Rx pain medications. • Encourage health insurance “flagging” of employees in health plans who may be misusing pain medications

  4. Employer Education • Impact and costs associated with Rx medication abuse and misuse • Promote adoption of drug-free workplace policies and workplace substance abuse prevention programs • Ensure that employee health and workers compensation benefit providers contracts include -- • provisions that address substance abuse treatment, • processes to identify doctor shopping, • reimbursement for providers for use of PDMP reports, and • “lock in” programs for patients whose prescribing history suggests they may be misusing Rx drugs.

  5. Public Education • How to identify overdoses and render emergency first aid. • Safe use of Rx medications and community approaches or models to prevent prescription drug overdoses. • Safe disposal of Rx medications to reduce oversupply and availability of these medications for misuse.

  6. Actions This YearIdentify Best Practices, Build Key Partnerships, Issue Guidelines for Employers • National Governors’ Association – work with 7 states to identify best practices in states, including desired/model legislation, regulations (July – March). • National Alliance of Model Drug Laws-- identify the existing laws/regulations in each state and how they compare to the models established in research. (August-January) • Centers for Disease Control and Prevention-- bring partners together from Federal government, state governments, public health, pharmaceutical industry, pharmacies and prescribers to build consensus on strategies and commitment to them from key sectors. (March). • NSC Whitepaper-- Educate employers on best practices in managing Rx use among employees and their families. (May-June).

More Related